- Report
- August 2025
- 470 Pages
Global
From €4258EUR$4,799USD£3,716GBP
- Report
- January 2025
- 143 Pages
Global
From €2262EUR$2,549USD£1,974GBP
€2661EUR$2,999USD£2,322GBP
- Report
- May 2025
- 156 Pages
Global
From €5279EUR$5,950USD£4,608GBP
- Report
- August 2025
- 200 Pages
Global
From €2209EUR$2,490USD£1,928GBP
- Report
- June 2025
- 200 Pages
Global
From €2209EUR$2,490USD£1,928GBP
- Report
- October 2025
- 184 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 190 Pages
Global
From €3145EUR$3,545USD£2,745GBP
€3495EUR$3,939USD£3,050GBP
- Report
- October 2025
- 197 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- October 2025
- 159 Pages
Global
From €5190EUR$5,850USD£4,530GBP
- Report
- September 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- September 2025
- 250 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- July 2025
- 175 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- March 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- February 2025
- 200 Pages
Global
From €3983EUR$4,490USD£3,477GBP
- Report
- July 2025
- 350 Pages
Global
From €4391EUR$4,949USD£3,833GBP
- Report
- May 2025
- 194 Pages
Global
From €4431EUR$4,995USD£3,868GBP
- Report
- August 2025
- 140 Pages
Global
From €3657EUR$4,123USD£3,192GBP
€4303EUR$4,850USD£3,756GBP
- Report
- September 2025
- 85 Pages
United States
From €3105EUR$3,500USD£2,710GBP
- Report
- April 2022
- 264 Pages
Global
From €5323EUR$6,000USD£4,646GBP
- Report
- March 2023
- 327 Pages
Global
From €3726EUR$4,200USD£3,253GBP

The Herpes Simplex Virus (HSV) is a virus that affects humans and is a major cause of genital herpes. It is a member of the Herpesviridae family and is divided into two types, HSV-1 and HSV-2. HSV-1 is the most common cause of oral herpes, while HSV-2 is the most common cause of genital herpes. In the biotechnology market, HSV is a major focus of research and development. Companies are working to develop treatments and vaccines to prevent and treat HSV infections. These treatments and vaccines are designed to target the virus itself, as well as the symptoms associated with HSV infections. Additionally, research is being conducted to develop diagnostic tests to detect HSV infections.
Companies in the HSV market include Gilead Sciences, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more